SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Curtin, F.
Right arrow Articles by Kaufmann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curtin, F.
Right arrow Articles by Kaufmann, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Flu
Hazardous Substances DB
*SERTRALINE
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Moclobemide discontinuation syndrome predominantly presenting with influenza-like symptoms

Francois Curtin

Clinical Psychopharmacology Unit, University Hospital of Geneva, Geneva, Switzerland; Swiss Agency for Therapeutic Products, Erlachstrasse 8, CH-3000 BERN 9, Switzerland; francois.curtin{at}swissmedic.ch

Patricia Berney

Christophe Kaufmann

Clinical Psychopharmacology Unit, University Hospital of Geneva, Geneva, Switzerland

A case of moclobemide discontinuation syndrome who predominantly presented with influenza-like symptoms is presented. Sertraline treatment did not modify the symptoms, which may suggest different mechanisms with regard to different antidepressant drug discontinuation syndromes. Implications for clinical care are reviewed.

Key Words: antidepressant • discontinuation syndrome • MAOI • moclobemide • SSRI

Journal of Psychopharmacology, Vol. 16, No. 3, 271-272 (2002)
DOI: 10.1177/026988110201600314
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement